These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon. Klee SR; Ozel M; Appel B; Boesch C; Ellerbrok H; Jacob D; Holland G; Leendertz FH; Pauli G; Grunow R; Nattermann H J Bacteriol; 2006 Aug; 188(15):5333-44. PubMed ID: 16855222 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Bacillus anthracis strains from Hungary. Kreizinger Z; Sulyok KM; Makrai L; Rónai Z; Fodor L; Jánosi S; Gyuranecz M Acta Vet Hung; 2016 Jun; 64(2):141-7. PubMed ID: 27342086 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Esel D; Doganay M; Sumerkan B Int J Antimicrob Agents; 2003 Jul; 22(1):70-2. PubMed ID: 12842331 [TBL] [Abstract][Full Text] [Related]
17. Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis? Drusano GL; Okusanya OO; Okusanya A; Van Scoy B; Brown DL; Kulawy R; Sörgel F; Heine HS; Louie A Antimicrob Agents Chemother; 2008 Nov; 52(11):3973-9. PubMed ID: 18725437 [TBL] [Abstract][Full Text] [Related]
19. Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis. Louie A; Heine HS; Kim K; Brown DL; VanScoy B; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL Antimicrob Agents Chemother; 2008 Jul; 52(7):2486-96. PubMed ID: 18458134 [TBL] [Abstract][Full Text] [Related]
20. Molecular diversity of Bacillus anthracis in the Netherlands: investigating the relationship to the worldwide population using whole-genome SNP discovery. Derzelle S; Girault G; Roest HI; Koene M Infect Genet Evol; 2015 Jun; 32():370-6. PubMed ID: 25843650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]